NIH Launches Trial Treatment for Rare Degenerative Muscle Disease

Published September 30, 2012

NIH Launches Trial Treatment for Rare Degenerative Muscle Disease

Filed under: Austin Drug Treatment

Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National … “This study marks an important milestone toward developing …
Read more on Opposing Views

JDRF announces Type 1 diabetes treatment competition winners

Filed under: Austin Drug Treatment

based Light White Innovation Technology owner Luz Blanco; University of Texas at Austin doctoral fellow Chen Xi and research partner Feng Siqian; and California Institute of Technology graduate students Mohsen Chitsaz and Alborz Mahdavi. … JDRF said …
Read more on Drug Store News